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Abstract Pregnancy, birth and adjusting to a new baby is a
potentially stressful time that can negatively affect the
health of women. There is some evidence that expressive
writing can have positive effects on psychological and
physical health, particularly during stressful periods. The
current study aimed to evaluate whether expressive writing
would improve women’s postpartum health. A randomized
controlled trial was conducted with three conditions:
expressive writing (n = 188), a control writing task
(n = 213), or normal care (n = 163). Measures of psycho-
logical health, physical health and quality of life were
measured at baseline (6–12 weeks postpartum), 1 and
6 months later. Ratings of stress were taken before and
after the expressive writing task. Intent-to-treat analyses
showed no significant differences between women in the
expressive writing, control writing and normal care groups
on measures of physical health, anxiety, depression, mood
or quality of life at 1 and 6 months. Uptake and adherence
to the writing tasks was low. However, women in the
expressive writing group rated their stress as significantly
reduced after completing the task. Cost analysis suggest
women who did expressive writing had the lowest costs in
terms of healthcare service use and lowest cost per unit of
improvement in quality of life. Results suggest expressive
writing is not effective as a universal intervention for all
women 6–12 weeks postpartum. Future research should
examine expressive writing as a targeted intervention for
women in high-risk groups, such as those with mild or
moderate depression, and further examine cost-effective-
ness.Clinical trial registration number ISRCTN58399513
www.isrctn.com
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Introduction
Approximately 136 million women every year give birth
(World Health Organization, 2005). For the majority of
women pregnancy and birth is positive, but some find the
challenge of adjusting to the physical and emotional
changes that accompany childbirth more difficult. Mental
health problems such as postpartum depression, anxiety
and post-traumatic stress can have a negative and enduring
effect upon women and their families (Glasheen et al.,
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2010; World Health Organization, 2016). The World
Health Organisation (WHO) lists mental illness as a sig-
nificant indirect cause of maternal mortality (WHO, 2014).
Maternal mental illness is associated with greater cogni-
tive, behavioural and interpersonal problems in young
children (Glasheen et al., 2010; Kingston & Tough, 2014).
Recently, the cost of maternal mental illness to UK society
was estimated at £8.1 billion per annual cohort of births,
with 72% of this cost being due to the impact on children
(Bauer et al., 2014).
Clinical guidelines emphasise the importance of early
intervention but also highlight the lack of evidence-based
interventions (National Institute for Health and Care
Excellence, 2014). There is a need to develop evidence-
based, low-risk interventions to improve physical and
mental health, regardless of the type or severity of symp-
toms experienced. By targeting women soon after birth,
postpartum interventions offer maximum scope for
enhancing the wellbeing of women and children. In
countries where healthcare is expensive and/or resources
low it is also important that interventions are cost-effective.
Expressive writing could potentially improve women’s
adjustment and health (Pennebaker & Chung, 2011) in a
low-risk and cost-effective manner. Expressive writing
interventions typically involve writing about one’s deepest
thoughts and feelings about a particular stressful event for
at least 15 min a day for 3 days (Pennebaker & Seagal,
1999; Smyth & Pennebaker, 2008). However, evidence for
the effectiveness of expressive writing is mixed. Many
studies have reported beneficial effects but the conclusions
of recent meta-analyses are contradictory. Frattaroli (2006)
reported small but significant beneficial effects of expres-
sive writing on physical and psychological health. In
contrast, Meads and Nouwen (2005) and Mogk et al.
(2006) concluded current evidence has not clearly
demonstrated its effectiveness but it may be beneficial for
some health outcomes in certain contexts. This is supported
by meta-analyses examining expressive writing within
particular samples, or for specific outcomes. For example,
Smyth (1998) reported a positive effect on physical and
psychological functioning in healthy populations; Frisina
et al. (2004) reported a small effect in clinical populations
for physical health, but not psychological health; Harris
(2006) concluded that it reduced healthcare utilisation in
healthy but not clinical populations; and van Emmerik
et al. (2013) concluded it is effective for reducing post-
traumatic stress and comorbid symptoms of depression.
To date, few studies have focused on postpartum
women, but the results are encouraging. Two studies found
it was helpful for mothers of babies needing special care.
Barry and Singer (2001) evaluated a non-standard form of
expressive writing with women whose babies were in
intensive care in the United States, and found that severe
distress reduced from 37 to 16%. Similarly, Horsch et al.
(2016) found that standard expressive writing reduced
symptoms of posttraumatic stress and depression in
mothers of very preterm infants. Other studies have
examined the effect of writing about labour and birth: a
series of studies by Di Blasio and colleagues found that
women who wrote expressively about labour and birth the
first week after birth had fewer symptoms of posttraumatic
stress 2 or 3 months postpartum (Di Blasio & Ionio, 2002;
Di Blasio et al., 2009; Di Blasio et al., 2015). Another
study using a variation of expressive writing called a
‘making sense’ intervention (where mothers wrote about
their labour and birth on one occasion in the first week
postpartum) found women had fewer symptoms of
depression and posttraumatic stress 3 months later than
those who did not write (Di Blasio et al., 2015).
The results of these studies are promising but further
investigation is needed (Peeler et al., 2013) as previous
studies have focused on specific groups; used variations of
the expressive writing paradigm; and many have insuffi-
cient power. This limits the extent to which results are
informative about the effectiveness of expressive writing in
the wider population of postpartum women and for a range
of health outcomes. This paper reports a randomized con-
trolled trial – the Health After Birth Trial (HABiT) – that
evaluated the effect of expressive writing on postpartum
mental health, quality of life and physical health; as well as
the costs associated with health service use and change in
health status.
Method
Design
HABiT was a parallel randomized controlled trial com-
paring expressive writing with a control writing task and
normal care. The primary outcome was changes in mental
health (mood, anxiety, depression). Secondary outcomes
were changes in quality of life and physical health (phys-
ical symptoms, overall self-rated health). Women were
randomized 6–12 weeks postpartum to one of three con-
ditions: expressive writing, a control writing task, or nor-
mal care. Outcomes were measured pre-intervention
(baseline), 1 and 6 months later. Costs were estimated
using healthcare utilisation and quality of life data.
Participants and procedure
Ethics permission was obtained from the National Health
Service (NHS) Research Ethics Committee. Sample size
calculations showed that to detect a small effect in primary
outcome measures with a significance level of 0.05 and
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80% power would require 122 women in each group,
giving a total sample of 366 women. Participants were
recruited through 14 NHS hospitals in England from
November 2013 to December 2014. Women were eligible
to participate if they were aged 18 years or older and had
given birth to a live infant after 26 weeks gestation.
Women who experienced stillbirth or neonatal death prior
to hospital discharge were excluded, but women with
current or previous psychological problems were not
excluded.
All eligible women (n = 7986) in 14 NHS hospitals
were invited to take part. Hospital based research staff put
flyers in women’s discharge packs. Four to six weeks after
birth they sent eligible women a letter inviting them to
participate in the study, along with a participant informa-
tion leaflet, consent form and reply paid envelope. Women
could elect to participate by post or internet. Those who
were willing to participate returned the consent form along
with their contact details direct to the research team.
Women who did not want to participate could reply giving
their reasons if they wished to do so.
Recruitment, allocation and sample attrition are shown
in Fig. 1. Of the women approached, 1413 replied and 854
consented to take part (10.69% of eligible sample). Ran-
domisation was initially on a 1:1:1 basis using a comput-
erised random number generator. Initial attrition from the
study was high, with 306 women failing to complete the
first workbook. Some women (n = 16) went on to complete
later measures, so baseline measures were imputed. The
final sample for analyses was therefore 564 women. As
dropout differed significantly between normal care and the
expressive/control writing groups (Crawley et al., 2018),
once there were enough participants in the normal care
group all remaining participants were randomized on a 1:1
basis to the expressive writing or control writing condi-
tions. There were no significant differences between
women who dropped out from the expressive writing or
normal care groups in age, parity or baseline measures of
depression, anxiety, physical health and quality of life.
Following randomisation, women participating by post
were sent workbook one with a reply-paid envelope.
Reminders were sent by post, email or text message if
workbooks were not returned within 10 days. Women
participating via the internet were enrolled in the online
system which generated an email or text message with their
username and password. Those who did not log on and
complete the workbook received further reminders after
7 days. Reminder times were slightly longer for postal
participants to account for the delay incurred between
postage and receipt of the workbooks. The majority of
women who were randomized chose to complete the study
online (63.2%). This did not differ between groups at the
point of randomisation (v2(2) = 1.65, p = .44) but did
differ for women who completed the study with more
women in the normal care group completing via post
(v2(2) = 7.55, p = .023).
All women completed baseline measures of mood,
anxiety, depression, physical health, quality of life, and
demographic measures (age, marital status, education,
ethnicity, employment and previous psychological history).
Women in the two writing conditions then completed the
3 day writing task, followed by additional measures of
mood, anxiety and depression. Those in the expressive
writing group also rated their stress before and after each
writing session to check that writing had not increased
stress. Follow-up measures of mood, anxiety, depression,
physical health, and quality of life were collected for all
groups at 1 and 6 months. Women in the control writing or
normal care groups were offered the expressive writing
intervention at the end of the study if they wished.
Interventions
Normal postpartum care in the UK consists of daily checks
by midwives and/or doctors whilst in hospital. After dis-
charge, women are visited at home by a community mid-
wife at least three times in the first 2 weeks (approximately
1, 5 and 10 days after discharge) or more if there are
complications or issues that require monitoring. From 10 to
12 days postpartum, women are under the care of their
general practitioner (GP) and have a routine check-up
6–8 weeks postpartum. Women are also assigned a com-
munity specialist nurse (health visitor) for maternal and
child health from 0 to 5 years postpartum.
The expressive writing intervention was based upon
Pennebaker’s expressive writing paradigm (Pennebaker &
Seagal 1999; Smyth & Pennebaker, 2008). Women were
instructed to write for 15 min each day about a stressful
event related to their pregnancy, birth, baby, or something
else going on in their life. Women were asked to write
about their ‘deepest thoughts and feelings’ about this event.
To avoid re-traumatising women the instructions stated that
if writing about this event felt too distressing or over-
whelming they should pick a less stressful event. Women
were asked to complete all three writing exercises within a
week, preferably on three consecutive days. Before and
after writing women in the expressive writing condition
were asked to rate ‘how upset or stressed are you by this
event or difficulty now?’ on a 10-point scale from 1 (not at
all) to 10 (extremely).
The control writing task was matched to the expressive
writing task for time and basic structure. Women were
asked to write about a familiar room, describing it objec-
tively and not writing about feelings, beliefs or opinions. A
measure of how clearly they could visualise the room from
1 (not at all) to 10 (extremely) was taken before and after
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the writing task. Women in both writing conditions were
asked to indicate how distracted they had been whilst
writing, and the date and time they started and stopped
writing was recorded automatically online or by self-report
in postal workbooks.
Measures
The primary outcome was changes in psychological health.
Secondary outcomes were changes in quality of life and
physical health. Questionnaire measures had been previ-
ously used and validated with peripartum women. Psy-
chological health was assessed in relation to mood, anxiety,
depression, and mental health related quality of life. Par-
ticipants also provided information about medication for a
psychological condition and current or previous psycho-
logical problems. Physical health was evaluated using a
symptom checklist, and physical health related quality of
life. All measures are outlined below.
Mood was measured using the University of Wales
Institute of Science and Technology Mood Adjective
Checklist (Matthews et al., 1990). This consists of 24 mood
adjectives. Participants indicate the extent to which each
adjective describes their current mood on a 4-point scale
(definitely, slightly, slightly not, definitely not). Some items
are reverse scored and higher scores indicate more positive
Eligible women
n = 7,986
Women who replied
n = 1,413
Excluded (n = 4)
No contact details = 4
Declined to participate (n = 555)
Too busy = 422
Not interested = 29
Too upsetting = 6
Poor health = 7
Against values = 1
Cultural beliefs = 1
Bereavement = 4
Other = 32
No reason = 21
Multiple reasons = 32
Randomised (n = 854)
Expressive Writing 
(n = 319)
Control Writing
(n = 334)
Normal Care
(n = 201)
Baseline 
(n = 188)
Received intervention 148
Baseline 
(n = 213)
Received intervention 182
Baseline 
(n = 163)
1-Month follow-up 
(n = 105)
1-Month follow-up 
(n = 121)
1-Month follow-up 
(n = 137)
6-Month follow-up 
(n = 86)
6-Month follow-up 
(n = 94)
6-Month follow-up 
(n = 110)
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Fig. 1 Sampling and attrition
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mood. The scale has good discriminant validity, is sensitive
to stressors and has been used in female and postpartum
samples. Internal reliability in our sample was high
(a = .93).
Mental Health was measured using the Hospital Anxiety
and Depression Scale (Zigmond & Snaith, 1983) which
was designed to assess psychological distress in patient
populations without being confounded by physical symp-
toms. It is therefore appropriate for postpartum women
where physical symptoms such as fatigue are common. It
comprises two 7-item subscales for anxiety and depression.
Each item is scored from 0 to 3, with some items reverse-
scored. Scores range from 0 to 21. Established cut-offs for
the UK population are 8–10 for mild symptoms, 11–14 for
moderate symptoms and 15 or more for severe symptoms.
Internal reliability in our sample was acceptable (a = .83
anxiety, and a = .79 depression).
Physical symptoms were measured using the Physical
Health Questionnaire-15 (Kroenke et al., 2002), a 15-item
somatic symptom checklist designed to measure the
severity of self-reported somatic symptoms and to screen
for somatoform disorders. The extent to which each item
has been bothersome over the previous two weeks is
recorded on a 3-point scale (not bothered, bothered a little,
bothered a lot). Higher scores indicate greater somatic
symptom severity: cut off points are 5 (low), 10 (medium)
and 15 (high) severity. Internal reliability in our sample
was acceptable (a = .73) as were psychometric properties
(Wilkie et al., 2017).
Quality of Life was measured using the Short Form
Quality of Life questionnaire, version 2 (Ware et al., 2000),
which is a widely used, standardised measure of quality of
life with good internal reliability in obstetric samples. It
comprises 12 questions about day-to-day functioning,
scored on a 5-point or 3-point scale. Responses are
imported into software purchased directly from the copy-
right holders which produces standardised z-scores for each
participant. These were summed to provide physical
health-related quality of life and mental health-related
quality of life subscales. High scores indicate better quality
of life. Internal reliability in our sample was accept-
able (a = .86).
Additional measures Basic obstetric details were recor-
ded from medical records. Use of healthcare services for
non-routine visits to a general practitioner or hospital for
women and their baby was measured by self-report at 1 and
6 months.
Health costs associated with each group were calculated
based on healthcare service use (GP visits, adult and pae-
diatric hospital admissions in days) as measured at the
1 month follow-up. Women were included if they com-
pleted measures of healthcare service use and quality of life
(n = 342). Data were skewed by two very high cost outliers
so these were removed.1 Unit cost data from published
sources (Curtis & Burns, 2015; Department of Health,
2013) were attached to the resource use for each participant
and multiplied to give total costs. Where necessary, esti-
mated costs were adjusted to account for inflation. Once all
resource use per participant had been calculated into a total
health services cost this was placed alongside changes in
participants’ physical and mental health quality of life
scores from baseline to the 1-month follow-up, so the mean
cost per unit of change in quality of life could be calculated
to allow for comparison across all trial arms.
Analysis
Analyses of demographic and outcome variables were
conducted using R (R Core Team, 2016). Demographic
variables were compared across treatment groups using Chi
square tests for categorical variables (e.g., ethnic group),
and a robust variant of a one-way ANOVA that corrects for
heteroscedasticity by generalising the Welch method for
continuous variables (e.g., age). The robust ANOVA was
implemented using Wilcox’s (2012) t1way function from
the WRS2 package (Mair et al., 2015; Wilcox, 2012).
Bayes factors using default priors were computed using the
BayesFactor package (Morey & Rouder, 2014) for each
variable to quantify the relative evidence for the null
against the alternative hypothesis. Values less than 1
indicate greater evidence for the null hypothesis (i.e.,
treatment groups did not differ).
The key outcomes were analysed using multilevel
models in which observations (level 1) were nested within
participants (level 2). For each outcome measure the model
was built hierarchically. To begin with, an intercept only
model (no predictors) was fit. Intercepts were then allowed
to vary across participants (random intercept), which
always improved the fit suggesting variability in mean
levels of each outcome across participants. Next intercepts
were allowed to vary across sites, but this addition never
significantly improved the fit of the model and was never
retained in the final model. The fixed effect of time
(baseline, 1 month, 6 months) was added, and then allowed
to vary across participants (random slopes). The random
slope of time always improved the fit suggesting variable
trajectories in all outcomes across participants. A first-
order autoregressive covariance structure (AR(1)) was then
imposed but in all but one model this model either did not
converge, or did not improve the fit and so was not
retained. Finally, the fixed effects of writing condition and
1 These outliers were a participant whose baby was in the neonatal
intensive care unit for 104 days (expressive writing group) and a
woman admitted to hospital after birth (normal care group).
618 J Behav Med (2018) 41:614–626
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its interaction with time was added. The final models can,
therefore be represented as (i = individual at time j):
Yij ¼ c00 þ c10Timeij þ c01Writingi

þ c11 Writingi  Timeij
 þ f0i þ f1iTimeij þ eij
 
These models were fit using the lme() function from the
nlme package (Pinheiro et al., 2015).
Results
Sample characteristics are shown in Table 1. The sample
was predominantly white European (94.7%), married or
cohabiting (95.1%) and educated to degree level or higher
(62.1%). The mean age of the participants was 32.77 years
(SD = 5.38; range 18 to 46 years). The majority of par-
ticipants were employed (n = 327; 83%) and a large pro-
portion of these worked in a professional occupation as
defined by the standard UK classification system (Office
for National Statistics, 2010) (n = 132; 41.8%). There were
no significant differences between intervention and control
groups on any sociodemographic or baseline measures of
outcomes.
Manipulation checks and adherence Analyses of the
tasks and adherence are reported in detail elsewhere
(Crawley et al., 2018). These showed the intervention was
effective in terms of content of writing. Writing groups did
not differ in the number of words written or time they took
to write, but did differ on content: expressive writing
participants used significantly more emotional and cogni-
tive processing words, but fewer perceptual words. How-
ever, adherence to the full writing protocol (to write for
15 min on three days) was low with only 29.3% of women
in the expressive writing group and 23.5% of women in the
control writing group complying with these instructions.
Adherence to the writing task was not predicted by type of
writing task (control vs. expressive writing), anxiety or
depression at baseline, education level, complications
during birth, parity, or mental health-related quality of life
at baseline. There were no significant differences between
writing groups in the potential confounding factor of how
distracted women were during the writing tasks (Crawley
et al., 2018).
Effectiveness of expressive writing on health outcomes
Table 2 shows the model parameters for the multilevel
models (see earlier description) for each health outcome.
The models were parameterized so that the main effect of
group was dummy coded comparing expressive writing
(the baseline) to normal care and control writing. The main
effects of group in these models show the effect of
expressive writing on health outcomes. This shows that
expressive writing had no significant effect on mood,
anxiety, depression or quality of life. There was a trend for
an effect of group on overall levels of physical symptoms
(p = .051), but change over time was not moderated sig-
nificantly by the writing condition. Similar results were
found when analyses were restricted to women who
adhered to the writing tasks (i.e. wrote for at least 15 min a
day on 3 days). Women who adhered were more likely to
have depression and physical symptoms at baseline.
Change over time was observed for most outcomes.
Overall levels and change varied across participants but
this change was not significantly moderated by writing
condition. Anxiety and depression reduced over time, with
a significant decrease observed at 1 month but not at
6 months. The quality of life mental health subscale scores
changed over time, with significant decreases observed at
1 month and 6 months, suggesting women’s quality of life
related to mental health worsened over time. Physical
symptoms significantly improved over time, as did quality
of life related to physical health.
Ratings of how stressed women in the expressive writ-
ing group were by the event they wrote about were anal-
ysed with a multilevel model in which ratings (level 1)
were nested within women (level 2). Fixed effects of time
(before vs. after writing), day (day 1, 2, or 3) and their
interaction were included. Intercepts for stress varied sig-
nificantly across women (LR = 470.02, p\ .001) and there
were significant main effects of time (LR = 7.44,
p = .006), and day (LR = 105.18, p\ .001), but not their
interaction (LR = 2.43, p = .30). Model parameters showed
that stress levels were significantly lower on day 2 than day
1 (b = -0.69, SE = 0.12, t(590) = -5.50, p\ .001), and
on day 3 compared to day 1 (b = -1.39, SE = 0.13,
t(590) = -10.70, p\ .001).
Potential moderators Unplanned exploratory analyses
were conducted to see how the effect size for expressive
writing compared to normal care changed as a function of
participants’ baseline anxiety and depression scores. This
was achieved by fitting a model to compare expressive
writing to normal care in subsets of participants defined by
threshold levels of depression or anxiety at baseline, and
then systematically increasing that threshold to examine
effect sizes for each point on the subscale. For example,
scores on the depression subscale at baseline ranged from 0
to 14 (from a possible range of 0 to 21). No participants
had severe depression at baseline (i.e. a score of 15 or
more). We began by setting the threshold at 0 and fitted the
model including all 544 participants (ns = 180 expressive
writing, 204 control writing, 160 normal care). The
threshold then moved to 1 (i.e. excluded cases with base-
line depression scores of 0) yielding a model based on 519
cases (ns = 169 expressive writing, 198 control writing and
152 normal care), then to 2 (i.e. excluding cases with
baseline depression below this value) to yield a model
J Behav Med (2018) 41:614–626 619
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Table 1 Sample characteristics
Total Sample Expressive Writing Control Writing Normal care Test statistic p
n % n % n % n %
Ethnicity
White European 373 94.7 102 94.4 118 92.2 153 96.8 Fisher’s exact test = 8.27 .338
African 3 0.8 1 0.9 1 0.8 1 0.6
Asian 5 1.3 3 2.8 2 1.6 – –
Mixed 5 1.3 – – 3 2.3 2 1.3
Other 8 2.0 2 1.9 4 3.1 2 1.3
394 108 128 158
Relationship status
Married 250 64.8 66 62.3 76 60.8 108 69.7
Cohabiting 117 30.3 36 34.0 42 33.6 39 25.2
Separated/divorced 4 1.0 2 1.9 – – 2 1.3 Fisher’s exact test = 9.82 .198
Single 13 3.4 2 1.9 7 5.6 4 2.6
Other 2 0.5 – – – – 2 1.3
386 106 125 155
Gestation
26\ 32 weeks 9 1.7 3 1.7 2 1 4 2.5 Fisher’s exact test = 3.15 .800
32\ 37 weeks 24 4.4 5 2.8 11 5.4 8 5.1
37\ 40 weeks 251 46.3 84 46.9 95 46.3 72 45.6
[ 40 weeks 258 47.6 87 48.6 97 47.3 74 46.8
542 179 205 158
Parity
Nulliparous 254 46.9 87 48.3 97 47.5 70 44.3 v2(2) = .61 .737
Multiparous 288 53.1 93 51.7 107 52.5 88 55.7
542 180 204 158
Type of birth
Normal vaginal 323 60.8 112 63.6 115 57.2 96 62.3 v2(6) = 3.47 .748
Assisted vaginal 70 13.2 25 14.2 27 13.4 18 11.7
Emergency caesarean 78 14.7 22 12.5 35 17.4 21 13.6
Elective caesarean 60 11.3 17 9.7 24 11.7 19 12.3
531 176 201 154
Complications
None 221 42.9 72 42.4 76 39.6 73 47.4 v2(8) = 7.62 .472
Maternal complications 145 28.1 45 26.5 59 30.7 41 26.6
Infant complications 83 16.1 34 20 28 14.6 21 13.6
Maternal and infant complications 67 13 19 11.2 29 15.1 19 12.3
516 170 192 154
Education level
None 4 1 2 1.9 1 0.8 1 0.6 Fisher’s exact test = .899
GCSE/O 49 12.7 11 10.3 16 13.1 22 14.1
A-Level 93 24.2 29 27.1 28 23 36 23.1
Degree + 239 62.1 65 60.7 77 63.1 97 62.2
385 107 122 156
Employment
Yes 327 83 90 83.3 103 80.5 134 84.8 v2(2) = .960 .620
No 67 17 18 16.7 25 19.5 24 15.2
394 108 128 158
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based on 455 cases (ns = 142 expressive writing, 177
control writing and 136 normal care), and so on until the
threshold was 12 and the model included only those 26
participants who scored 12 or more at baseline (ns = 7
expressive writing, 12 control writing and 7 normal care).
Results suggest that the effect of expressive writing was
greatest in women who had mild to moderate symptoms of
depression at baseline (i.e. a score of 9 or more; see Figure,
Supplemental Digital Content 1). However, this finding
needs to be treated very cautiously because (1) it was not
planned a priori; (2) as the threshold level of depression for
inclusion increases the sample size decreases, therefore, the
apparent influence of baseline depression is confounded by
the lack of precision with which we can estimate the effect
of expressive writing; and (3) the subsample of women
with a depression score of 9 or more at baseline was small
(ns = 36 expressive writing, 30 control writing and 18
normal care), and estimates are more variable in small
samples. As such, this finding requires replication. Levels
of anxiety at baseline did not affect the effect of expressive
writing.
Cost analysis The mean cost associated with health
service resource use in different groups was: £517 for
expressive writing, £721 for control writing, and £657 for
normal care. This is a saving of £140 compared to normal
care (or 19% of costs of normal care). When mean cost
data was considered alongside mean change in physical
health quality of life for each group, the associated cost per
unit of improvement was £138 for the expressive writing
group, £192 for the control writing group and £201 for the
normal care group: a saving of £63 compared to normal
care (or 31% of costs of normal care). Mean costs per unit
of change in mental health showed a similar pattern, with
the cost per unit of change being lowest for the expressive
writing group (£346) and highest for the normal care group
(£570). However, changes in scores on the mental health
quality of life subscale from baseline to the 1-month follow
up were small so this should be interpreted with caution.
Discussion
The HABiT trial aimed to examine the efficacy of
expressive writing for improving postpartum health.
Results show expressive writing was not effective as a
universal intervention for women 6–12 weeks after birth.
However, in the expressive writing group stress associated
with the event they wrote about significantly decreased
after writing. Cost analysis suggest women who did
expressive writing had the lowest costs in terms of
healthcare service use and costs per unit of improvement in
quality of life. Exploratory moderator analyses suggested
expressive writing may be more effective in women with
mild to moderate depression but this requires replication.
These results are consistent with some studies in non-
obstetric samples. Meta-analyses of the effects of expres-
sive writing report mixed findings (Frattaroli, 2006; Meads
& Nouwen, 2005; Mogk et al., 2006; Smyth, 1998; Frisina
et al., 2004; van Emmerik et al., 2013). Some conclude that
although participants who write often feel it is beneficial
the evidence does not clearly demonstrate its effectiveness
(Meads & Nouwen, 2005; Mogk et al., 2006). The finding
that expressive writing was associated with lowest costs for
healthcare service use is consistent with the meta-analysis
by Harris (2006) which found that expressive writing
reduced healthcare service use in healthy populations but
not clinical populations.
Mogk et al. (2006) acknowledge that expressive writing
may be beneficial for some health outcomes in certain
contexts. In HABiT, women were more likely to adhere to
the writing tasks if they had greater physical symptoms and
depression. Similar results have been found in other studies
(Broderick et al., 2004). Possible explanations include that
people with greater symptoms at baseline are more moti-
vated to adhere to expressive writing; more likely to ben-
efit; and/or that expressive writing is more likely to be
effective when fully adhered to.
The results of HABiT are inconsistent with previous
studies with postpartum women, where all the published
research to date has found positive benefits of expressive
writing (Barry & Singer, 2001; Horsch et al., 2016; Di
Table 1 continued
Total Sample Expressive Writing Control Writing Normal care Test statistic p
n % n % n % n %
Diary writing
Regularly 14 3.6 3 2.8 4 3.1 7 4.5 Fisher’s exact test = 2.56 .870
Sometimes 53 13.5 14 13 21 16.4 18 11.5
Rarely 63 16 19 17.6 21 16.4 23 14.6
Not at all 263 66.9 72 66.7 82 64.1 109 69.4
393 108 128 157
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Table 2 Effectiveness of expressive writing
b SE t Value df P b SE t Value df P
Anxiety Depression
Intercept 6.43 .30 21.64 636 \ .001 4.98 .26 19.07 636 \ .001
1 month follow up - .59 .26 - 2.31 636 .022 - .74 .25 - 2.95 636 .003
6 months follow up - .36 .34 - 1.05 636 .295 - .48 .38 - 1.26 636 .209
Expressive writing versus Control
writing
.28 .41 .68 550 .496 .11 .36 .31 550 .756
Expressive writing versus Normal care - .29 .43 - .66 550 .508 - .56 .38 - 1.46 550 .145
1 month follow up: EW versus Control
writing
.21 .35 .59 636 .556 .38 .34 1.12 636 .264
6 months follow up: EW versus
Control writing
.39 .47 .82 636 .414 .26 .53 .51 636 .614
1 month follow up: EW versus Normal
care
.45 .34 1.32 636 .187 .38 .33 1.14 636 .254
6 months follow up: EW versus
Normal care
.36 .46 .80 636 .423 .18 .51 .35 636 .724
Model fit: Time v2 - 3101.08 AIC 6212.16 BIC 6237.59 5 .046 v2 - 3050.94 AIC 6111.87 BIC 6137.30 5 .009
Model fit: Group v2 - 3087.32 AIC 6198.65 BIC 6259.68 12 .378 v2 - 3020.67 AIC 6065.34 BIC 6126.37 12 .064
Model fit: Group x Time interaction v2 - 3086.24 AIC 6204.47 BIC 6285.85 16 .704 v2 - 2019.81 AIC 6071.62 BIC 6153.00 16 .789
Quality of Life (Mental Health) Quality of Life (Physical Health)
Intercept 41.41 .44 93.21 624 \ .001 55.6 .68 82.12 622 \ .001
1 month follow up - 1.33 .54 - 2.44 624 .015 3.68 .69 5.33 622 \ .001
6 months follow up - 2.42 .62 - 3.91 624 \ .001 4.9 .89 5.51 622 \ .001
Expressive writing versus Control
writing
- .13 .61 - .21 538 .834 - .28 .93 - .30 538 .767
Expressive writing versus Normal care .04 .64 .06 538 .951 .70 .98 .71 538 .479
1 month follow up: EW versus Control
writing
.05 .74 .06 624 .949 - .32 .95 - .34 622 .733
6 months follow up: EW versus
Control writing
1.04 .85 1.22 624 .224 - 1.3 1.22 - 1.06 622 .290
1 month follow up: EW versus Normal
care
.23 .74 .31 624 .753 - .30 .94 - .32 622 .750
6 months follow up: EW versus
Normal care
.13 .85 .16 624 .874 - 1.29 1.21 - 1.06 622 .289
Model fit: Time v2 - 3609.10 AIC 7228.20 BIC 7253.53 5 \ .001 v2 - 4004.84 AIC 8019.68 BIC 8045.00 5 \ .001
Model fit: Group v2 - 3598.70 AIC 7221.39 BIC 7282.18 12 .922 v2 - 3973.42 AIC 7972.84 BIC 8038.67 13 .413
Model fit: Group x Time interaction v2 - 3597.38 AIC 7226.77 BIC 7307.82 16 .622 v2 - 3972.57 AIC 7979.14 BIC 8065.23 17 .790
Mood Physical Symptoms
Intercept 5.56 1.22 44.82 604 \ .001 7.13 .31 23.29 616 \ .001
1 month follow up - 1.11 1.05 - 1.06 604 .290 - .92 .29 - 3.19 616 .002
6 months follow up - .32 1.39 - .23 604 .817 - 1.24 .42 - 2.93 616 .004
Expressive writing versus Control
writing
.52 1.67 - .32 525 .754 .22 .42 .52 532 .601
Expressive writing versus Normal care 3.21 1.76 1.82 525 .069 - .52 .44 - 1.16 532 .247
1 month follow up: EW versus Control
writing
1.85 1.44 1.29 604 .199 .66 .40 1.66 616 .096
6 months follow up: EW versus
Control writing
1.59 1.92 .83 604 .406 .59 .58 1.01 616 .311
1 month follow up: EW versus Normal
care
- .26 1.4 - .18 604 .856 - .05 .39 - .13 616 .898
6 months follow up: EW versus
Normal care
- .31 1.85 - .17 604 .869 .86 .57 1.52 616 .130
Model fit: Time v2 - 4544.55 AIC 9099.10 BIC 9124.28 5 .689 v2 - 3089.62 AIC 6189.23 BIC 6214.50 5 .001
Model fit: Group v2 - 4522.99 AIC 9069.98 BIC 9130.43 12 .179 v2 - 3070.06 AIC 616412 BIC 6224.76 12 .051
Model fit: Group x Time interaction v2 - 4521.53 AIC 9075.05 BIC 9155.64 16 .570 v2 - 3066.19 AIC 6164.38 BIC 6245.23 16 .101
Bold values indicate outcome measure
EW expressive writing
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Blasio & Ionio, 2002; Di Blasio et al., 2009; Di Blasio
et al, 2015; Di Blasio et al., 2015). A few of these studies
sampled high-risk women who are likely to be distressed
i.e. women with babies born preterm or in NICU (Barry &
Singer, 2001; Horsch et al., 2016), whereas HABiT used
systematic sampling to try to get a representative, norma-
tive cohort. It is therefore possible that expressive writing
is more likely to be effective when it is targeted at par-
ticular groups of high-risk women. Exploratory threshold
analysis of HABiT data provided some support for this,
with a suggestion that the effect of expressive writing may
be greater in women with mild to moderate depression
scores at baseline. However, as there were very few women
in this sample with mild to moderate depression this
analysis requires replication.
Timing of the intervention is also likely to be important,
as the demands of caring for a new baby may make it
difficult for women to find time to write regularly without
distractions, especially in the early postpartum period. In
previous studies women either wrote in the first week, often
whilst they were still in hospital (Di Blasio & Ionio, 2002;
Di Blasio et al., 2009; Di Blasio et al., 2015; Di Blasio
et al., 2015), or after 3 months postpartum (Barry &
Singer, 2001; Horsch et al., 2016). In HABiT women were
recruited at 4–6 weeks postpartum and asked to complete
the writing task 6–12 weeks postpartum, which may have
been a factor in the low uptake and adherence. The
acceptability and feasibility of expressive writing to post-
partum women at different times and in different contexts
may help explain our inconsistent findings. Crawley et al.
examine the feasibility and acceptability of expressive
writing in HABiT and conclude that the feasibility of using
expressive writing as a universal intervention for all
women 6–12 weeks after birth is low because of the poor
uptake and high levels of dropout. However, for women
who use expressive writing it is an acceptable intervention
(Crawley et al., 2018).
Outcome measures should also be considered. Previous
studies with postpartum women focused on psychological
outcomes of posttraumatic stress, distress and depression,
and found positive effects of expressive writing. HABiT
extended these findings by examining quality of life,
physical symptoms and costs associated with healthcare
service use and improved quality of life. However, HABiT
did not include a measure of posttraumatic stress because
such symptoms were not expected to be common in a
normative sample. A meta-analysis of expressive writing
for posttraumatic stress in multiple populations concluded
it is effective for reducing posttraumatic stress and
comorbid symptoms of depression (van Emmerik et al.,
2013). This may be an important outcome to include in
future research with high-risk postpartum women.
Although expressive writing did not improve health
outcomes when used as a universal intervention for all
women, it also did not do harm. Women who did the
expressive writing task found it acceptable, reported
reduced stress about the event they wrote about, and were
generally positive about expressive writing (Crawley et al.,
2018). This is consistent with previous literature. For
example, a meta-analysis of emotional disclosure which
found no positive effects of emotional disclosure on a
range of health outcomes also observed that there were no
negative effects (Meads et al., 2003). Thus, if expressive
writing is offered as one of a range of self-help interven-
tions then women who self-select to do it (for whatever
reason) may be more likely to adhere and gain benefit from
it even if it does not improve health outcomes. Further
research is needed to examine this.
Expressive writing was also associated with the lowest
healthcare costs. The results suggested that, compared to
normal care, expressive writing was associated with a 19%
saving in healthcare service use and a 31% saving in costs
per unit of improvement in physical health quality of life
compared to normal care. Similar findings were also
observed for costs for mental health. This is consistent with
meta-analyses which find that expressive writing reduces
healthcare service use in healthy populations but not clin-
ical populations (Harris, 2006; Meads et al., 2003). Harris
(2006) suggests that expressive writing may address con-
cerns in people who use healthcare services frequently by
helping them explore and satisfy their concerns, thus
reducing use of healthcare services. In HABiT many
women wrote about health concerns with the baby or
themselves so it is possible that this acted to reduce
healthcare service costs. Of course, it is impossible to
determine whether this is positive or negative in terms of
health outcomes, only that it reduces healthcare service
costs. Further research is needed to establish the cost-ef-
fectiveness of expressive writing with postpartum women,
the mechanisms underlying this effect, and what impact it
has on health outcomes.
Strengths and limitations
Strengths of this study include being the first study to
evaluate expressive writing as a universal intervention for
all postpartum women. It is also the largest randomized
controlled trial examining expressive writing in this pop-
ulation to date. Outcomes measures were carefully chosen
to be valid in this population. Limitations are the low
uptake and adherence rates, which shows the feasibility of
using expressive writing so early in the postpartum period
is poor. The low uptake also means the sample is not
representative of the population, with a high proportion of
white European women educated to degree level or above.
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Results are therefore not generalizable to all postpartum
women and future research is needed with women from
ethnic minority groups or lower levels of education.
Implications for research and practice
This study has a number of implications for clinical prac-
tice. A major consideration is the use of expressive writing
(and perhaps self-help interventions generally) as a uni-
versal or targeted intervention. Universal interventions are
applied to all women in a prophylactic manner with the aim
of aiding adjustment and positive health. This approach in
HABiT resulted in low uptake and high dropout. There are
many possible explanations for this, such as the interven-
tion being offered too early postpartum, as discussed
above. In addition, it could be speculated that women who
did not have problems adjusting postpartum, or who had
severe problems adjusting, may have been less motivated
to take part.
In contrast, targeted interventions are offered to women
with specific characteristics as a form of prevention or
treatment, such as in previous studies of expressive writing
for women with preterm babies (Horsch et al., 2016), or the
possibility suggested here of offering expressive writing to
women with mild to moderate depression after birth. The
results of HABiT clearly show the universal application of
expressive writing is not warranted or feasible in the early
postpartum period. However, there are many possible
reasons for this and further research is needed to examine it
as a targeted intervention for high-risk women.
There are also implications for research. This discussion
has outlined some of the ways in which sampling, timing of
interventions, type of writing task and outcome measures
may all influence whether expressive writing is effective
for postpartum women. Future research should consider
sampling high-risk groups, offering the intervention when
women have time, such as whilst in hospital or after
3 months postpartum, including outcome measures of
posttraumatic stress, and conducting further cost analyses
of healthcare service use.
Conclusion
In conclusion, this study shows that expressive writing is
not effective as a universal intervention for women
6–12 weeks after birth. These results are consistent with
some studies of expressive writing in other populations
(Meads & Nouwen, 2005; Mogk et al., 2006), but not
consistent with research with postpartum women (Barry &
Singer, 2001; Horsch et al., 2016; Di Blasio & Ionio, 2002;
Di Blasio et al., 2009; Di Blasio et al., 2015; Di Blasio
et al., 2015). This is probably due to methodological dif-
ferences such as sampling and timing of the intervention.
However, expressive writing was associated with reduced
self-rated stress and healthcare use and costs. This is con-
sistent with meta-analyses showing expressive writing is
associated with reduced healthcare use in healthy samples
(Harris, 2006; Meads et al., 2003).
Poor uptake and adherence to the writing tasks suggests
expressive writing is not feasible for many women at this
time (Crawley et al., 2018). Women who adhered to the
expressive writing task had more physical symptoms and
depression so may have been more motivated to complete
it, although symptoms of depression were very mild in this
sample and within the normal range. There is some sug-
gestion that expressive writing may be more effective in
women with mild to moderate depression. Future research
should therefore examine expressive writing as a targeted
intervention for women in high risk groups, such as those
with mild to moderate depression, and look at the mecha-
nisms underlying reduced healthcare costs and any impact
this has on health outcomes.
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